Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) has earned an average rating of “Hold” from the fifteen ratings firms that are covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, five have assigned a hold rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average 12-month price target among brokers that have issued ratings on the stock in the last year is $29.8462.
A number of research analysts have recently weighed in on ACHC shares. KeyCorp lifted their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research report on Tuesday, July 14th. UBS Group raised their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 9th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Wednesday, September 9th. Guggenheim increased their price objective on shares of Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a research note on Thursday, July 30th. Finally, TD Cowen raised their price objective on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th.
Get Our Latest Stock Analysis on Acadia Healthcare
Hedge Funds Weigh In On Acadia Healthcare
Acadia Healthcare Trading Up 2.3%
NASDAQ:ACHC opened at $28.81 on Friday. Acadia Healthcare has a one year low of $11.43 and a one year high of $35.83. The business has a fifty day moving average price of $30.21 and a 200-day moving average price of $27.18. The firm has a market capitalization of $2.68 billion, a price-to-earnings ratio of -2.31, a price-to-earnings-growth ratio of 9.07 and a beta of 0.62. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.03. The company had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.Acadia Healthcare’s quarterly revenue was down .4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Sell-side analysts forecast that Acadia Healthcare will post 1.55 EPS for the current year.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The company operates facilities that offer treatment for mental health conditions, substance use disorders and other behavioral health needs. Its services are designed for children, adolescents and adults and may include inpatient psychiatric care, residential treatment, outpatient programs and specialized care.
Acadia’s facilities provide a range of treatment programs, including psychiatric hospitals, addiction treatment centers, eating disorder programs and other specialty behavioral healthcare services.
Further Reading
- Five stocks we like better than Acadia Healthcare
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
- The Fed’s Rate Hike Could Backfire If Oil Prices Collapse
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
